Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Rani Therapeutics  (Stock symbol: RANI )

2051 Ringwood Avenue
San Jose, CA 95131
Website Company Summary Management Team

CEO: Mir Imran (6/30/2012)
General Management: Mike Billig
Finance: Syed Zaidi (2/28/2012) ; Svai Sanford (5/13/2019)
Technology: Mir Hashim
Business Development: Stephanie McGrory
General Counsel/Legal: Angela Murch ; Eric Groen
Former Employees: Peter Herrmann Robert Gaffney

Outside board: (May no longer be on the board) Dennis Ausiello (Massachusetts General Hospital Former Chief of Medicine)
Advisory board: Peter Barton Hutt (Covington & Burling Sr. Counsel) Bill Ringo (Sofinnova Investments Strategic Advisor) Fabrizio Bonanni (Amgen Former EVP) Maulik Nanavaty (Boston Scientific SVP & Division President)

Business description: Rani Therapeutics has developed the RaniPill™, a platform technology for the oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs that today can only be injected. These injections are painful and inconvenient and often affect both patient compliance and quality of life. The pharma industry has been searching for decades to convert injectables into pills, and we believe the solution is the RaniPill™ capsule. We have demonstrated bioavailability similar to subcutaneous injections in both preclinical and clinical studies. Rani has an internal pipeline of molecules, and active collaborations with Novartis and Takeda. The research and technology behind Rani Therapeutics came out of InCube Labs, a multi-disciplinary life sciences R&D lab focused on breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur, and investor.
Partners include: MedImmune

Rounds: 4
Recent Fundings: Dec 2020   Feb 2018
Capital raised: 211.0M
Last Round: 69.0M
Ownership: Private   Ipo Filing
Stock Symbol: RANI
VCs include: InCube Ventures;  Shire ;  Pacific Venture Opportunity Fund;  Pinemount Investment;  Crystal Horizon Investments;  The Stevanato Group;  VentureHealth ;  Western Life Sciences Venture Fund;  Virtus Inspire Ventures ;  Bossa Nova Investments ;  GeneScience Pharmaceuticals ;  Cathay Venture ;  Nan Fung Life Sciences
Corporate investors: NovartisAstraZeneca GV

Last Tweets


Last Mentions

Record updated: Sep 2021
Sector: Biotech
Year Founded: 2012
Headcount: 26-50 as of Jul 2021
Rounds: 4
Recent Fundings: Dec 2020   Feb 2018
Capital Raised: 211.0M
Last Round: 69.0M
Ownership: Private   Ipo Filing
Stock Symbol: RANI